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The nature of stable DNA adducts derived from the very potent carcinogen dibenzo[a,l]pyrene
(DB[a,l]P) in the presence of rat liver microsomes in vitro and in mouse skin in vivo has been
studied using 32P-postlabeling and laser-based fluorescence techniques. Analysis of DB[a,l]P-
DNA adducts via 32P-postlabeling has been obtained by comparison of the adduct patterns to
those obtained from reactions of synthetic (()-anti-, (+)-anti-, (-)-anti-, and (()-syn-DB[a,l]P-
11,12-diol 13,14-epoxide (DB[a,l]PDE) with single nucleotides and calf thymus DNA. anti-
DB[a,l]PDE-dA adducts derived from the (-)-enantiomer are the major adducts formed in
calf thymus DNA and in mouse skin DNA. The ratio of deoxyadenosine to deoxyguanosine
modification is approximately 2:1 in mouse skin exposed to DB[a,l]P; activation by rat liver
microsomes leads to a similar profile of adducts but with two additional spots. The
conformations of DB[a,l]P adducts in native DNA, as well as the possibility of conformation-
dependent repair, have been explored by low-temperature fluorescence spectroscopy. These
studies have been performed using polynucleotides and calf thymus DNA reacted in vitro with
DB[a,l]PDE and native DNA from mouse epidermis exposed to DB[a,l]P. The results show
that adducts are heterogeneous, possess different structures, and adopt different conformations.
External, external but base-stacked and intercalated adduct conformations are observed in
calf thymus DNA and in mouse skin DNA samples. Differences in adduct repair rates are
also revealed; namely, the analysis of mouse skin DNA samples obtained at 24 and 48 h after
exposure to DB[a,l]P clearly shows that external adducts are repaired more efficiently than
intercalated adducts. These results, taken together with those for B[a]P-DNA adducts [Suh
et al. (1995) Carcinogenesis 16, 2561-2569], indicate that the repair of DNA damage resulting
from PAH diol epoxides is conformation-dependent.
Introduction
Dibenzo[a,l]pyrene (DB[a,l]P1) is a very potent car-
cinogen that requires enzymatic activation in biological
systems to exhibit its biological activity via covalent DNA
binding by electrophilic reactive metabolites (1-9). DB-
[a,l]P belongs to a group of hexacyclic aromatic hydro-
carbons that exhibit a range of carcinogenic activity on
mouse skin (1, 7, 8) and in rat mammary gland (1, 7).
Dibenzopyrenes have been found to be present in tobacco
smoke particulates (10), in coal tar, and in air, food, and
water contaminated with combustion products (11). The
carcinogenic activity of DB[a,l]P has been found to be
significantly stronger than that of 7,12-dimethylbenz[a]-
anthracene and benzo[a]pyrene (B[a]P), which were
previously considered to be the most potent and widely
studied carcinogenic polycyclic aromatic hydrocarbons
(PAH) (7, 8).
As revealed by adduct analysis in cell cultures, biotrans-
formation of DB[a,l]P to DNA-binding metabolites results
in the formation of fjord region syn- and anti-11,12-diol
13,14-epoxides (DB[a,l]PDE) (4-6), which have been
reported to be extraordinarily strong mutagens and
carcinogens (12-15). However, it appears that monooxy-
genation is not the exclusive pathway of metabolic
activation of DB[a,l]P. On the basis of the analysis of
DNA adducts produced after activation of DB[a,l]P in
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vitro by liver microsomes from 3-methylcholanthrene-
induced rats, Li et al. reported that DB[a,l]P adduct
formation also occurs by the one-electron oxidation
metabolic pathway (9). Furthermore, Li et al. reported
that the major DNA adducts formed in vitro by these two
pathways are unstable due to rapid depurination reac-
tions involving cleavage of the glycosidic bond. The
relevance of apurinic sites is discussed in detail in refs
16 and 17.
Analytical techniques which require digestion of DNA
to the nucleotide level provide no insight on adduct
conformation in the double-stranded helix. Nevertheless,
adduct conformation is believed to play a major role in
the biological effects of adducts, notably during replica-
tion and during DNA repair (18, 19). In the case of
B[a]P-DNA adducts, the repair rate in mouse skin was
found to depend on adduct conformation, with interca-
lated and base-stacked external adducts being more
persistent than adducts having an external conformation
(20). The hypothesis that intercalated adducts are
generally repaired less efficiently than helix-external
adducts needs to be tested through experiments with
other carcinogenic PAH.
Theoretical (21) and experimental (22) studies sug-
gested that the same adduct is likely to adopt different
conformations with different biological consequences.
Geacintov (23, 24) obtained evidence via linear dichroism
studies which was most easily interpreted in terms of a
single adduct giving rise to multiple conformations.
NMR studies of the B[a]P-derived monooxygenation
adducts also indicated the presence of multiple conforma-
tions (24). Loechler et al. (25, 26) reported that B[a]P
diol epoxide-derived adduct conformation is a key factor
controlling the types of mutation at the lesion site.
Various types of heterogeneity, i.e., due to structurally
distinct and/or energetically inequivalent conformers,
heterogeneity provided by an inhomogeneous environ-
ment of DNA, and polynucleotides have been discussed
in ref 27.
In the present study a comparative investigation of
stable DNA adduct formation of DB[a,l]P in the presence
of rat liver microsomes in vitro and in mouse skin in vivo
has been undertaken using the 32P-postlabeling and
HPLC techniques. Analysis of DB[a,l]P-DNA adducts
was performed by comparison of the adduct patterns
with those obtained from reactions of synthetic (()-anti-,
(+)-anti-, (-)-anti-, and (()-syn-DB[a,l]PDE with single
nucleotides and calf thymus (CT)-DNA. The chemical
structures of the fjord region diol epoxides of DB[a,l]P
are shown in Figure 1. The conformations of DB[a,l]P-
DNA adducts and the possibility of conformation-depend-
ent repair have been explored by low-temperature fluo-
rescence spectroscopy. Fluorescence measurements have
been performed using polynucleotides and CT-DNA
reacted in vitro with DB[a,l]PDE, and native DNA from
mouse skin exposed to DB[a,l]P.
This study provides direct comparison of two different
approaches for DNA adduct analysis, i.e., 32P-postlabeling
HPLC and low-temperature fluorescence spectroscopy,
and shows that both methods not only complement each
other but also provide consistent results. In addition to
the characterization and quantitation of adducts at the
nucleotide level by the 32P-postlabeling approach, low-
temperature laser-excited fluorescence methods allow for
differentiation between various conformations of DB[a,l]P
adducts in native DNA and reveal differences in their
repair rates in mouse skin exposed to DB[a,l]P. Thus,
the results presented here support our earlier findings
(20) that adduct repair is conformation-dependent.
Materials and Methods
Caution:DB[a,l]P and DB[a,l]PDE are hazardous chemicals;
they should be handled in accordance with NIH guidelines.
Adduct Formation with CT-DNA, Polyoligonucleotides,
and Nucleoside 3′-Monophosphates of Deoxynucleoside
3′-Monophosphates. Poly(dG)¥poly(dC) or poly(dA)¥poly(dT)
(0.1 íg/íL), nucleoside 3′-monophosphate of deoxyribonucleoside
3′-monophosphates (0.1 íg/íL), or CT-DNA (2.0 íg/íL) in 0.1
M Tris-HCl buffer (pH 7.4, 500 íL total volume) was mixed with
50 íg (0.142 ímol) of syn- or anti-diol epoxide dissolved in 50
íL of dimethyl sulfoxide. After incubation at 37 °C for 4 h the
reaction mixture was extracted with 500 íL of water-saturated
ethyl acetate (three times) and subsequently with 500 íL of
water-saturated diethyl ether (twice) to remove excess of
unreacted diol epoxide and/or its hydrolysis products. The
extraction mixture was efficiently separated each time by
centrifugation (13 000 rpm). In the case of the modified
oligonucleotides and CT-DNA, ethanol (2 volumes) and NaCl
(5 M, 0.1 volume) were subsequently added to the solution,
which was then kept overnight at -20 °C to complete the
precipitation. The modified oligonucleotide or CT-DNA, sepa-
rated by centrifugation for 30 min (13 000 rpm), was rinsed with
aqueous ethanol (70%), centrifuged again, and dried under
vacuum. In experiments with modified nucleotide 3′-monophos-
phates of deoxyribonucleoside 3′-monophosphates, the aqueous
phase was used directly without further precipitation. Dena-
turation of adducted poly(dA)¥poly(dT) in buffer solution was
obtained via heating to 90 °C and rapid cooling to either 77
or 4.2 K.
DB[a,l]P-Modified DNA from Incubations with Rat
Liver Microsomal Fractions. Rat hepatic microsomal frac-
tions were prepared from 3-methylcholanthrene-treated animals
using the method described by Tierney et al. (28). DB[a,l]P (0.1
ímol) was incubated with the microsomal preparation in the
presence of cofactors and DNA, as described by Hughes and
Phillips (29).
DB[a,l]P-Modified DNA from Mouse Skin. Groups of
four male Parkes mice (6-8 weeks old) purchased from the MRC
Figure 1. Structures of the four possible fjord region diol
epoxides of dibenzo[a,l]pyrene. In the present study, optically
active (+)-anti-(11S,12R,13R,14S)- and (-)-anti-(11R,12S,
13S,14R)-diol epoxides and a racemic mixture of the (+)- and
(-)-syn-(11R,12S,13R,14S)-diol epoxides were used.
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National Institute for Medical Research (Mill Hill, London, U.K.)
were treated with DB[a,l]P; 1 ímol in 200 íL of acetone per
mouse was applied to shaved areas of their backs. Control
animals received acetone only. Groups of four animals were
killed by cervical dislocation at 24 and 48 h after treatment.
Treated areas of the skin were removed and frozen; DNA was
isolated as described by Hughes and Phillips (3, 29).
32P-Postlabeling. DNA from mouse skin and from incuba-
tions with rat liver microsomal preparations was digested
enzymatically and 32P-postlabeled using the nuclease P1 diges-
tion procedure to enhance the sensitivity of the assay, as
described previously (3). DNA and 3′-mononucleotides that had
been reacted with DB[a,l]P diol epoxides were analyzed using
the standard 32P-postlabeling procedure (30). Resolution of the
32P-labeled adducts was carried out on 10-  10-cm poly-
(ethylenimine) cellulose TLC plates using solvent system I
described previously (29): D1, 1.0 M sodium phosphate (pH 6.0);
D2, 3.5 M lithium formate, 8.5 M urea (pH 3.5); D3, 0.8 M
lithium chloride, 0.5 M Tris-HCl, 8.5 M urea (pH 8.0); D4, 1.7
M sodium phosphate (pH 6.0). To improve resolution of the
adduct spots, solvents D2 and D3 were run onto short paper
wicks (4 cm in length), in addition to the usual procedure which
also involves running solvents D1 and D4 onto wicks.
HLPC Analysis. After quantitation on TLC, adduct spots
were eluted with pyridinium formate (4 M, pH 4.5, 500 íL)
overnight and the eluates filtered and evaporated to dryness.
The residues were redissolved in deionized water (100 íL) before
injection onto a Zorbax phenyl-modified reverse-phase column
(250  4.6 mm; particle size, 5 ím). Elution was with the
following solvent system: 0-15 min, a linear gradient of 10-
46% buffer B (methanol-buffer A, 9:1) in buffer A (the composi-
tion of buffer A was 0.3 M sodium dihydrogen orthophosphate
and 0.2 M orthophosphoric acid, adjusted to pH 2.0); 15-60 min,
a linear gradient of 46-48% B in buffer A; 60-80 min, a linear
gradient of 48-80% B in buffer A, all at a flow rate of 1.2 mL/
min. Phenanthrene-9,10-diol was used as an internal marker,
with a retention time of approximately 40 min (31).
Low-Temperature Fluorescence Spectroscopy. A de-
tailed description of the apparatus used for fluorescence line-
narrowing (FLN) and non-line-narrowing (NLN) spectroscopy
is given elsewhere (32). Briefly, the excitation source was a
Lambda Physik FL-2002 dye laser pumped by a Lambda Physik
EMG 102 MSC XeCl excimer laser. The cryostat was a double-
nested glass Dewar fitted with quartz optical windows. For
gated detection of fluorescence signals, the output of a reference
photodiode was used to trigger a high-voltage gate pulse
generator to define the temporal observation window of a
Princeton Instruments IRY 1024/G/B intensified photodiode
array. Various delay times and gate widths were utilized (see
figure captions). A 1-m focal length McPherson 2061 mono-
chromator was used to disperse the fluorescence. For high-
resolution measurements the monochromator was equipped
with a 2400 grooves/mm grating, providing an 8-nm spectral
window. FLN spectra were acquired using many different laser
excitation wavelengths, each revealing a portion of the S1
excited-state vibrational frequencies of the analyte. Low-
resolution NLN fluorescence spectra were recorded using the
same monochromator fitted with a 150 grooves/mm grating,
yielding a 160-nm window. Various laser excitation wave-
lengths and different observation windows (i.e., detector delay
times) were used to reveal adduct heterogeneity; only selected
spectra are shown below.
All samples were studied in aqueous buffer to mimic the
situation in a cellular environment (30). DNA samples were
dissolved in 30-40 íL of 20 mM sodium phosphate buffer (pH
7.0; 100 mM NaCl), and the resulting solutions (DNA concen-
tration 3 mM in base pairs) were transferred to quartz tubes
for spectroscopic analysis at 77 and 4.2 K. Ethanol-precipitated
solid pellets of mouse skin DNA were also analyzed for com-
parison. Synthesized polynucleotide-DB[a,l]PDE samples were
dissolved in 30 íL of 20 mM sodium phosphate buffer. To
eliminate any dependence on cooling rate (34), samples were
kept on ice for at least 20 min before rapid cooling in liquid
helium (for FLN) or liquid nitrogen (for NLN fluorescence
measurements).
Results
32P-Postlabeling. 1. DNAAdducts inMouse Skin.
32P-Postlabeling analysis of DNA isolated from the skin
of mice that had been topically treated with DB[a,l]P is
shown in Figure 2B. The chromatogram reveals the
presence of three major adducts (spots 1-3) and four
minor adducts (spots 4-7). The pattern of adduct spots
is essentially the same for DNA samples isolated at 24
and 48 h after treatment. The total adduct level at 24 h
is 63.1 fmol/íg of DNA (2082 adducts/108 3′-nucleotides)
and at 48 h is 46 fmol/íg of DNA (1518 adducts/108
3-′nucleotides) (3). The relative amounts of radioactivity
in each adduct spot for DNA isolated at 24 h are given
in Table 1.
2. DNA Adducts from Rat Liver Microsomal
Incubations. The pattern of adducts obtained with
DNA that had been incubated with DB[a,l]P and rat liver
microsomal fractions is shown in Figure 2A. The same
seven adducts seen in mouse skin are observed (spots
1-7), with two additional minor spots (8 and 9). The
relative amounts of radioactivity in each spot are given
in Table 1.
Adducts Formed by Diol Epoxides Reacted with
DNA and Mononucleotides. 1. (-)-anti-DB[a,l]-
PDE. The products of the reaction of this diol epoxide
with DNA, dGp, and dAp are shown in Figure 2C,D,E,
respectively. Three major adducts (spots 1-3) and two
minor adducts (spots 5 and 6) are formed with DNA. By
comparing the patterns of adduct spots in Figure 2C-E,
it is clear that two of the adducts formed in the reaction
of this diol epoxide with DNA involve modification of
guanine (spots 1 and 5) and three are adenine adducts
(spots 2, 3, and 6). An extra spot (spot 10, Figure 2E) is
observed only for the reaction with dAp.
2. (+)-anti-DB[a,l]PDE. Four major adducts (spots
2 and 11-13) and three minor adducts (spots 14-16) are
formed with DNA, as shown in Figure 2F. Of these, two
involve modification of guanine (spots 11 and 12; compare
with Figure 2G), and three are adenine adducts (spots
13-15; compare with Figure 2H). Two extra spots (spots
2 and 16) are observed only for the reaction of this diol
epoxide with DNA, leading to the possible conclusion that
they involve reaction with cytosine.
3. (()-syn-DB[a,l]PDE. As shown in Figure 2I, (()-
syn-DB[a,l]PDE forms four major adducts (spots 1*, 4,
7, and 8) and three minor adducts (spots 17-19) with
DNA. Of these, two involve reaction with guanine (spots
8 and 17; compare with Figure 2J), and four involve
reaction with adenine (spots 1*, 4, 7, and 19; compare
with Figure 2K). A minor adduct (spot 18) is observed
only for the reaction of this diol epoxide with DNA,
suggesting that it is possibly a cytosine adduct. The
relative intensities of all the adduct spots formed by diol
epoxides reacted with DNA and 3′-mononucleotides are
summarized in Table 1.
Identification of Adducts Formed in Mouse Skin
and Rat Liver Microsomal Incubations. 1. Thin-
Layer Chromatography. The results of the 32P-post-
labeling experiments are summarized in Table 2, where
the adduct patterns observed for DNA isolated from
mouse skin and rat liver microsomes are compared to
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those obtained by reaction of the diol epoxides with DNA
and 3′-mononucleotides. In mouse skin exposed to DB-
[a,l]P, seven adducts (spots 1-7) are observed: five of
the seven adducts in mouse skin are formed by (-)-anti-
DB[a,l]PDE (spots 1-3, 5, and 6 in Figure 2A), and two
minor adducts are formed by (()-syn-DB[a,l]PDE (spots
4 and 7). One major adduct (spot 1) and one minor
adduct (spot 5) are formed with guanine residues, and
the rest involve modification of adenine. Thus the ratio
of guanine to adenine modification (for the DNA samples
obtained after 24 h and the dose of DB[a,l]P used) is
approximately 1:2 in mouse skin exposed to DB[a,l]P. The
activation of DB[a,l]P by rat liver microsomes leads to a
similar profile of adducts, but with two extra spots (8 and
9 in Figure 2B). Adduct spot 8 results from the reaction
of (()-syn-DB[a,l]PDE with guanine residues. Adduct
spot 9 did not comigrate with any of the synthetic
adducts; its identity is therefore unknown.
Adduct spot 1 in the mouse skin and rat liver mi-
crosome experiments, which appears to consist primarily
of a (-)-anti-DB[a,l]PDE adduct with guanine, may also
Figure 2. 32P-Postlabeling autoradiographs of DB[a,l]PDE
adducts from (A) DNA from rat liver microsomal incubations
with DB[a,l]P in vitro; (B) mouse skin DNA exposed (24 h) to
DB[a,l]P in vivo; (-)-anti-DB[a,l]PDE reacted with DNA (C),
with dGp (D), and with dAp (E); (+)-anti-DB[a,l]PDE reacted
with DNA (F), with dGp (G), and with dAp (H); (()-syn-DB[a,l]-
PDE reacted with DNA (I), with dGp (J), and with dAp (K).
Table 1. 32P-Postlabeling Analysis of DB[a,l]P-DNA
Samples Isolated at 24 h
sample
adduct spot
numbera
total
radioactivity
(%)
DNA from mouse skin exposed to 1 25.7 ( 2.1
DB[a,l]Pb (Figure 2B) 2 28.1 ( 9.5
3 32.8 ( 5.0
4 1.6 ( 0.7
5 7.2 ( 0.2
6 3.3 ( 0.3
7 1.4 ( 1.6
DNA from rat liver microsomal 1 + 4 + 8 36.8 ( 1.3
incubations with DB[a,l]Pb 2 27.4 ( 3.2
(Figure 2A) 3 17.9 ( 3.7
5 + 6 14.8 ( 1.9
7 0.9 ( 1.0
9 2.3 ( 2.5
(-)-anti-DB[a,l]PDE and CT-DNA 1 16.6
(Figure 2C) 2 30.6
3 24.7
5 + 6 28.0
(-)-anti-DB[a,l]PDE and dGp 1 30.9
(Figure 2D) 5 69.1
(-)-anti-DB[a,l]PDE and dAp 2 6.5
(Figure 2E) 3 40.6
6 25.9
10 27.0
(+)-anti-DB[a,l]PDE and CT-DNA 2 17.9
(Figure 2F) 11 29.2
12 14.4
13 30.1
14 4.3
15 1.3
16 2.8
(+)-anti-DB[a,l]PDE and dGp 11 13.3
(Figure 2G) 12 86.7
(+)-anti-DB[a,l]PDE and dAp 13 62.3
(Figure 2H) 14 7.7
15 30.0
(()-syn-DB[a,l]PDE and CT-DNA 1* 8.7
(Figure 2I) 4 10.2
7 9.0
8 50.7
17 6.8
18 12.6
19 1.9
(()-syn-DB[a,l]PDE and dGp 8 86.7
(Figure 2J) 17 13.3
(()-syn-DB[a,l]PDE and dAp 1* 42.1
(Figure 2K) 4 45.9
7 8.2
19 3.8
a As shown in Figure 2. b The mean ( standard deviation of four
determinations.
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contain a minor contribution from a (()-syn-DB[a,l]PDE
adduct with adenine (spot 1* in Figure 2K). In addition,
adduct spot 2, which is primarily due to a (-)-anti-DB-
[a,l]PDE adduct with adenine, may also contain a com-
ponent resulting from the reaction of (+)-anti-DB[a,l]PDE
with DNA that is not formed with dGp or dAp.
HPLC. To confirm the adduct designations made on
the basis of TLC mobility, adduct spots were excised and
the radioactivity was eluted and further chromato-
graphed on HPLC. The results are summarized in Table
3. Adduct spot 1 from mouse skin (Figure 2B) gave a
single peak with a retention time between 45 and 50 min
(Table 3). Adduct 1 from the reaction of (-)-anti-DB-
[a,l]PDE with dGp (Figure 2D) also gave a single peak
with similar retention time; when coinjected on to HPLC,
the two products gave a single radioactive peak. Adduct
1 from the microsomal incubations (Figure 2A) also gave
a peak at this retention time that coeluted with adduct
1 from the reaction of (-)-anti-DB[a,l]PDE with dGp, but
it also gave other radioactive peaks between 20 and 30
min. Similar analyses of adduct 3 from skin, microsomal
incubation and in vitro reaction (Figure 2B,A,E, respec-
tively) gave in each case a single peak eluting at between
71 and 74 min; coinjection resulted in radioactivity
coeluting as a single peak in each case (chromatograms
not shown). For adduct 5 (Figure 2A,B,D), single peaks
of radioactivity at 34 min were obtained in each case,
and these coeluted with each other when coinjected onto
HPLC. For adduct 6 (Figure 2A,B,E), the same result
was obtained with the adduct from microsomal incuba-
tions and the corresponding in vitro adduct (retention
time 42 min), but insufficient radioactivity was obtained
from mouse skin DNA to perform satisfactory coinjection
experiments, even though this material eluted as a single
peak with a similar retention time.
However, the results with adduct spot 2 (Figure
2A,B,E) displayed greater complexity. HPLC analysis
resulted in the elution of several peaks; in each of the
three cases there was a peak eluting between 55 and 61
min; for mouse skin DNA and microsomal incubations
another peak was seen at 21 min, and for the in vitro
reaction product [from the reaction of (-)-anti-DB[a,l]-
PDE with dAp] there was an additional major peak at
74 min. Coinjection experiments revealed that the mouse
skin and in vitro peaks between 50 and 60 min coeluted.
Insufficient radioactivity was eluted from spots 4 and 7
to permit further analysis on HPLC.
Low-Temperature Fluorescence Spectroscopy.
In this section DNA adducts are assessed by laser-
induced fluorescence spectroscopy, performed under line-
narrowing (at 4.2 K) and non-line-narrowing (S2 r S0
laser excitation at T ) 77 K) conditions. Various excita-
tion wavelengths were used; only selected spectra are
presented. It is shown below that time-resolved spec-
troscopy and selective laser excitation provide a means
for structural adduct assignment. The data shown
establish that DB[a,l]PDE-derived DNA adducts exist in
multiple conformations.
1. External versus Intercalated Adduct Confor-
mations. DB[a,l]P adducts having their fluorescence
origin band at wavelengths shorter or longer than 395
nm are labeled as external and intercalated, respectively
(see Discussion section). The presence of different adduct
conformations is demonstrated in Figure 3 by NLN
fluorescence spectra of (()-anti-DB[a,l]PDE-poly(dA)¥poly-
(dT) adducts before (spectrum a) and after (spectrum b)
denaturing the sample. The (0,0) band of the major
adduct of (()-anti-DB[a,l]PDE-poly(dA)¥poly(dT) is lo-
cated at 398 nm (curve a). Upon denaturation to the
single-stranded polynucleotide, the origin band shifts to
382.6 nm (curve b). Similar spectra were observed for
the (-)-anti-DB[a,l]PDE-poly(dA)¥poly(dT) adducts (spec-
tra not shown). The FLN spectrum obtained for the
denatured sample (curve c, Figure 3) is different from
FLN spectra obtained for tetrols derived from anti-DB-
[a,l]PDE (35). The spectra were also different from the
FLN spectra obtained for the physical complexes of DB-
[a,l]P tetrols with DNA (data not shown). This indicates
that the origin band at 382.6 nm does not correspond to
Table 2. DB[a,l]P-DNA Adducts from Mouse Skin, Rat Liver Microsomal Incubations, and Chemical Reactions
adduct
number
(-)-anti-
DE/DNA
(+)-anti-
DE/DNA
(()-syn-
DE/DNA
(-)-anti-
DE/dGp
(+)-anti-
DE/dGp
(()-syn-
DE/dGp
(-)-anti-
DE/dAp
(+)-anti-
DE/dAp
(()-syn-
DE/dAp
1/1a x xa x xa
2 x xb x
3 x x
4 x x
5 x x
6 x x
7 x x
8c x x
9c
a A minor spot from (()-syn-DB[a,l]PDE/dAp comigrates with a major spot from (-)-anti-DB[a,l]PDE/dGp. b (+)-anti-DB[a,l]PDE/DNA
gives a minor spot that comigrates with spot 2, but (+)-anti-DB[a,l]PDE did not give this spot with either dGp or dAp. Therefore, this
(+)-anti-DB[a,l]PDE/DNA adduct may involve modification of cytosine. c These adducts form in DNA from rat liver microsomal incubations,
but not in mouse skin. Adduct 9 did not comigrate with any of the synthetic adducts formed from reactions of these diol epoxides with
DNA, dAp, or dGp.
Table 3. Retention Times on HPLC of Adduct Spots
Eluted from TLC
retention time (min)
adduct
spot
mouse
skin
(A)
microsomal
incubation
(B)
in vitro
adduct
(C)
A + C
coinjected
B + C
coinjected
1 48 44 45 45 44
2 21, 55 21, 55, 61 59, 74 50, 70 -
3 73 74 71 71 71
4 - - - - -
5 34 34 34 34 34
6 49 42 42 - 42
7 - - - - -
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hydrolysis products but to a dA adduct. Thus the two
fluorescence origin bands at 382.6 and 398 nm are most
likely associated with different conformations of the same
adduct in different DNA conformations, external and
intercalated, respectively.
2. (()-anti-DB[a,l]PDE Adducts with Polynucle-
otides. NLN fluorescence spectra for adducts resulting
from binding of (()-anti-DB[a,l]PDE to poly(dG)¥poly(dC)
are shown in Figure 4. Curves a and b were obtained
for two different excitation wavelengths, but otherwise
identical conditions. Spectrum a was obtained with 308-
nm excitation. This wavelength has poor selectivity that
excites both external and intercalated conformations (20)
and reveals the fluorescence emission from all adducts.
The weak peak indicated by the dashed arrow is most
likely due to a tetrol hydrolysis product (35). Spectrum
b was obtained with excitation at 360 nm; data obtained
for different excitation wavelengths revealed that the
360-nm wavelength excites more selectively the interca-
lated adducts. Apparently, the intercalated adducts must
have much stronger absorption extinction coefficient (in
that region) than the external adduct types. The result-
ing fluorescence (0,0) band is located at 398 nm. The
difference spectrum (a - b) shows the existence of an
adduct fraction having more helix-external character and
a blue-shifted emission maximum at 394.2 nm. All of
these spectra show the characteristic vibronic progression
of benzo[e]pyrene, the fluorescent chromophore (35, 36).
The contribution from the external adducts could also be
revealed by exploiting differences in fluorescence life-
times of the external and intercalated adducts. A
spectrum very similar to the difference spectrum (a - b)
in Figure 4 was obtained as the difference between
spectra obtained at 0- and 50-ns delay times for ìex )
360 nm (data not shown). This was possible because, as
established in the course of this work, the external adduct
type has a shorter fluorescence lifetime than the inter-
calated adducts (80 versus 130 ns), and therefore,
when using a shorter detector delay time, a larger
contribution from this conformational subpopulation was
revealed. Other examples of this procedure will be shown
below. Since (()-anti-DB[a,l]PDE has been shown to
react predominantly with purine bases (4-6, 9, 33, 37),
it is reasonable to assume that the adducts formed with
poly(dG)¥poly(dC) correspond to dG adducts formed via
either cis or trans opening of the epoxide (see Discussion).
The spectroscopic characteristics of DB[a,l]PDE-
adenine adducts obtained from the reaction of (()-anti-
DB[a,l]PDE with poly(dA)¥poly(dT) are shown in Figure
5. Spectra a and b were acquired with excitation
wavelengths of 308 and 360 nm, respectively. Again, the
difference spectrum (a - b) reveals the contribution from
helix-external adducts, but this contribution is much
weaker than that observed in Figure 4 for poly(dG)¥poly-
(dC). The external (()-anti-DB[a,l]PDE-poly(dA)¥poly-
(dT) adducts possess a shorter fluorescence lifetime
compared to the intercalated adducts, so the external
adduct fraction can also be revealed via time-resolved
spectroscopy. This is shown in Figure 5c, which is the
spectrum obtained as the difference between spectra
measured using two different detector delay times (0 and
50 ns), but the same laser wavelength (360 nm). Similar
results were obtained for 308-nm excitation. The tem-
poral difference spectrum (c) reveals the spectrum of the
component having the shorter fluorescent lifetime, the
external adduct conformation. Note that the difference
Figure 3. NLN fluorescence spectra of anti-DB[a,l]PDE-poly-
(dA)¥poly(dT) before (spectrum a) and after (spectrum b) dena-
turing the oligonucleotide. Both spectra were obtained for ìex )
360 nm at T ) 77 K. The FLN spectrum (curve c; ìex ) 372 nm,
T ) 4.2 K) of anti-DB[a,l]PDE-poly(dA) is different from the
FLN spectra of DB[a,l]P tetrols (tetrol spectra not shown).
Figure 4. NLN fluorescence spectra (T ) 77 K) of adducts from
(()-anti-DB[a,l]PDE bound to poly(dG)¥poly(dC). Spectra a and
b were obtained at 50-ns delay time for ìex ) 308 and 360 nm,
respectively. The (0,0)int origin band is located at 398 nm. The
difference spectrum (a - b) shows the existence of an adduct
fraction with more helix-external character and (0,0) band at
394.2 nm.
Figure 5. NLN fluorescence spectra (T ) 77 K) of adducts from
(()-anti-DB[a,l]PDE bound to poly(dA)¥poly(dT). Spectra a and
b were obtained for ìex ) 308 and 360 nm, respectively, and a
50-ns delay time. The spectrum a - b is the difference between
spectra a and b, while curve c is a temporal difference spectrum
between spectra acquired at 0- and 50-ns delay times with ìex
) 360 nm.
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spectrum (c) also reveals a broad band at 445 nm. This
band, observed only at very short delay times, corre-
sponds to excimer type fluorescence which was not
observed for the poly(dG)¥poly(dC) oligonucleotide samples
(see Table 4).
3. (()-anti-DB[a,l]PDE Adducts with DNA. Fluo-
rescence spectra of adducts resulting from the reaction
of (()-anti-DB[a,l]PDE with CT-DNA are shown in
Figure 6. Comparison of spectrum a, acquired using
nonselective excitation at 308 nm, and spectrum b,
acquired using more selective excitation at 360 nm, also
indicates the presence of at least two adduct conforma-
tions. In addition to intercalated adducts having a red-
shifted fluorescence (0,0) band at 398 nm, the DNA
sample also contains external adducts, possibly a mixture
of dGext and dAext adducts, as shown in the difference
spectrum (Figure 6, a-b). The origin band for these
adducts is located at 393.5 nm. The presence of this
subpopulation is also shown in spectrum c, the temporal
difference spectrum for fluorescence spectra acquired
using two different detector delay times (0 and 50 ns).
The broad fluorescence emission feature at 445 nm
observed for the DNA sample was also present in the (()-
anti-DB[a,l]PDE-poly(dA)¥poly(dT) sample and is due to
excimer fluorescence from adducts bound to neighboring
bases.
4. (()-syn-DB[a,l]PDE Adducts with Polynucle-
otides and DNA. NLN fluorescence spectra of (()-syn-
DB[a,l]PDE adducts in double-stranded poly(dG)¥poly-
(dC) acquired with two different excitation wavelengths
are shown in Figure 7. Spectrum a was obtained using
nonselective excitation at 308 nm, while spectrum b
corresponds to intercalated adducts selectively excited at
370 nm. The difference spectrum (a - b) reveals adducts
having an external conformation, which are less ef-
ficiently excited at 370 nm. The origin band for this
fraction is located at 392.6 nm. A minor contribution
from another adduct having an even more external
character is observed at 382.5 nm.
Adducts from the reaction of (()-syn-DB[a,l]PDE with
poly(dA)¥poly(dT) and with CT-DNA also exhibit both
external and intercalated conformations, along with a
contribution from excimer fluorescence at approximately
440 nm (spectra not shown). The results are summarized
in Table 4 along with the spectral characteristics of all
the adducts described above.
5. DB[a,l]P Adducts in Mouse Epidermis DNA.
Figure 8 shows fluorescence spectra of mouse skin DNA
Table 4. Summary of Adduct Conformations, Based on Low-Temperature Fluorescence Spectra, Formed in Duplex
Polynucleotides and DNA in Vitro from Reaction with (()-anti- and (()-syn-DB[a,l]PDE
(()-anti-DB[a,l]PDE (()-syn-DB[a,l]PDE
sample
adduct
label
(0,0)
band (nm) conformation assignment
adduct
label
(0,0)
in (nm) conformation assignment
poly(dG)¥poly(dC)a - (()-1 382.5 syn-dGextb
(()-2 394.2 anti-dGext (()-2 392.6 syn-dGextb
(()-3 398 anti-dGint (()-3 399 syn-dGint
poly(dA)¥poly(dT) (()-2 393.4 cis-anti-dAext (()-2 392.5 syn-dAext
(()-3 398 anti-dAint (()-3 399 syn-dAint
c 445 two anti-dAext on neighboring bases c 440 two syn-dAext on neighboring bases
CT-DNA (()-2 394.2 anti-dGext and anti-dAext (()-2 392.6 syn-dGext and syn-dAext
(()-3 398 anti-dGint and/or anti-dAint (()-3 399 syn-dAint and/or syn-dGint
c 445 two anti-dAext (a minor contribution) c 440 two syn-dAext (a large contribution)
a No excimer fluorescence was observed for the poly(dG)¥poly(dC) samples. b These two external adducts likely have similar conformations
of the cyclohexenyl ring but different DNA base-stacking interactions. c External adducts bound to neighboring or closely spaced adenine
bases, as revealed by excimer-type fluorescence.
Figure 6. Fluorescence spectra of adducts from the in vitro
reaction of (()-anti-DB[a,l]PDE with CT-DNA, obtained for ìex
) 308 nm and 50-ns delay time (spectrum a) and for ìex ) 360
nm and 100-ns delay (spectrum b). Spectrum a - b is the
difference between spectra a and b. Spectrum c is the temporal
difference spectrum for two fluorescence spectra obtained at
different detector delay times, 0 and 50 ns.
Figure 7. NLN spectra of (()-syn-DB[a,l]PDE adducts in a
double-stranded poly(dG)¥poly(dC) oligonucleotide; T ) 77 K.
Spectrum a was obtained using nonselective excitation at 308
nm, while spectrum b was obtained using selective excitation
of intercalated adducts at 370 nm. The difference spectrum a -
b reveals the adduct fraction having an external conformation
with (0,0) band at 392.6 nm [(()-2]. A minor contribution from
another adduct with an even more external character is
observed at 382.5 nm [(()-1].
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obtained at two different time points after exposure to
DB[a,l]P, 24 h (Figure 8a) and 48 h (Figure 8b). The
highest level of binding was detected 24 h after treat-
ment; at 48 h the total adduct level had decreased as a
result of DNA repair processes (see 32P-postlabeling
results). By comparing spectra a and b in Figure 8
measured under identical conditions, it is possible to
determine which adduct conformation is being removed
more efficiently. The difference spectrum (a - b) is
almost identical to that for the external anti-DB[a,l]-
PDE-dA adduct observed in poly(dA)¥poly(dT) (Figure
5, a - b) but is different from those of the external (()-
anti-DB[a,l]PDE-dG, (()-syn-DB[a,l]PDE-dG, and (()-
syn-DB[a,l]PDE-dA adducts. In addition to the external
anti-dA adduct, there is a minor adduct (origin band at
382.5 nm, labeled by the dashed arrow in Figure 8) which
is also removed in the 24-48-h time period. This band
is not due to tetrol degradation (hydrolysis) products,
since the fluorescence spectra of DB[a,l]P tetrols in the
presence of DNA are red-shifted to 387 nm, due to
physical complexation. This adduct most likely corre-
sponds to a minor trans-syn-DB[a,l]PDE-dG adduct (see
Discussion for details). In summary, these results show
that the external adducts are preferentially removed in
the time frame from 24 to 48 h.
To positively identify the efficiently repaired anti-DB-
[a,l]PDE-dAext adduct fraction in mouse skin DNA, FLN
spectra for the DNA samples and trans- and cis-anti-DB-
[a,l]PDE mononucleotide-dAMP adduct standards have
been acquired. There are significant differences in the
vibrational frequencies between trans-anti-DB[a,l]PDE-
dAMP and cis-anti-DB[a,l]PDE-dAMP adducts that
enable spectral distinction between these two adducts.2
There are characteristic modes at 348, 396, 860, 915, 932,
and 960 cm-1 for the cis-anti-DB[a,l]PDE-dAMP2 ad-
duct, while trans-anti-DB[a,l]PDE-dAMP adduct has
modes at 748, 773, 803, 842, and 926 cm-1. A detailed
comparison of FLN spectra obtained at different excita-
tion wavelengths showed that only the FLN spectra of
cis-anti-DB[a,l]PDE-dAMP featured the same vibra-
tional frequencies as those observed for the mouse skin
DNA samples. An example of FLN spectra for cis-anti-
DB[a,l]PDE-dAMP [with (0,0) band at 390 nm] and
mouse skin DNA [with (0,0) band at 392 nm] is shown
in Figure 9, spectra a and b, respectively. These spectra
were obtained with different excitation wavelengths
(376.0 and 378.0 nm) in order to compensate for the shift
of their respective fluorescence (0,0) origin bands (see
Discussion). On the basis of the agreement of the
vibrational frequencies in the FLN spectra shown in
Figure 9, the efficiently repaired anti-dAext adducts
formed in mouse skin DNA can be assigned as a cis-anti-
DB[a,l]PDE-dA adduct, in an external conformation.
Discussion
Vibronic Intensity Distribution. Before discussing
adduct heterogeneity, conformations, and repair, we
would like to address the different vibronic intensity
distributions observed in the NLN fluorescence spectra
obtained for various DB[a,l]PDE-derived adducts. Dif-
ferent vibronic intensity distributions have previously
been observed for stereoisomeric tetrols derived from syn-
and anti-DB[a,l]PDE (35) and nucleoside-dA adducts.2
For cis-anti- and trans-syn-DB[a,l]P tetrol, the (0,0) band
is the strongest feature in the fluorescence spectrum. In
contrast, trans-anti- and cis-syn-DB[a,l]P tetrol exhibit
stronger long wavelength emission bands compared to
their fluorescence origin bands. External dA adducts on
a single-stranded poly(dA) chain also have relatively
strong vibronic bands, as shown in Figure 3b. Appar-
ently, there is an increased probability of transition from
the excited electronic state to higher vibrational levels
of the ground state, as indicated by intensified long
wavelength emission bands. The differences observed
arise most likely from the fact that some vibronic bands
are forbidden in the Condon approximation but can
derive their intensities through vibronic coupling (38, 39).
Thus, on the basis of the NLN spectra presented here,
we conclude that also in the case of DB[a,l]PDE-derived
DNA adducts (with B[e]P chromophore, C2V symmetry)
2 Devanesan, P. D., Ariese, F., Jankowiak, R., Small, G. J., Rogan,
E. G., and Cavalieri, E. L. A novel method for the isolation and
identification of stable DNA adducts of dibenzo[a,l]pyrene and dibenzo-
[a,l]pyrene diol epoxide formed in vitro. Chem. Res. Toxicol., submitted.
Figure 8. NLN fluorescence spectra (ìex ) 360 nm, detector
delay time 25 ns) of DNA from mouse skin epidermis obtained
at two different time points after exposure to DB[a,l]P: 24 h
(curve a) and 48 h (curve b). Spectrum a - b is the difference
between spectra a and b, while curve c is the spectrum of the
external anti-DB[a,l]PDE-dA [(()-2] adduct observed in poly-
(dA)¥poly(dT) oligonucleotide (same as Figure 6, curve (a - b).
Figure 9. FLN spectra of cis-anti-DB[a,l]PDE-dAMP standard
adduct (spectrum a) and the 24-h mouse skin DNA sample
(spectrum b), obtained at 4.2 K for excitation wavelengths of
376.0 and 378.0 nm, respectively (see text). The FLN peaks are
labeled with their S1 excited-state vibrational frequencies, in
cm-1.
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the vibronic intensity distribution is strongly conforma-
tion-dependent and is caused by vibronically induced
mode mixing and conformationally induced symmetry
changes (distortion from planarity). To interpret the
spectroscopic results, however, it is enough to consider
the wavelengths of the fluorescence (0,0) bands listed in
Tables 4 and 5.
Multiple Adduct Conformations. Our key spectro-
scopic findings regarding (()-anti- and (()-syn-DB[a,l]-
PDE-derived DNA and polynucleotide adducts, utilizing
time-resolved spectroscopy and selective laser excitation,
are in agreement with previous studies of B[a]P-DNA
adducts which showed that adducts may exist in external
and intercalated conformations (20). Detailed studies
have shown that a strong interaction between the B[a]P
chromophore and the DNA helix leads to a red shift and
spectral broadening, while the spectra of mononucleotide
adducts are blue-shifted and fairly sharp (20). Based on
the extent of the red shift observed for the fluorescence
origin band of the pyrenyl fluorescence spectrum and
strength of the electron-phonon coupling, it has been
shown that anti-B[a]PDE-DNA adducts can exist in
helix-external [(()-1], partially based-stacked [(()-2], and
intercalated [(()-3] conformations (20). We have now
found that DB[a,l]PDE-derived adducts also adopt mul-
tiple conformations. As in the case of B[a]PDE adducts,
DB[a,l]PDE adducts will also be designated by (()-1, (()-
2, and (()-3, to denote their conformations. The conven-
tion adopted in our group is that the S1 state energy
(energy of the fluorescence origin band) decreases with
increasing number associated with the (()-adduct label.
Alternatively, adducts have also been classified by other
workers (23, 24) as type I (intercalated), type II (exter-
nal), or type II′ (external, with partial base stacking) (33).
Thus, an adduct having its (0,0) band at 383 nm is
assigned as (()-1 [or type II according to Geacintov’s
terminology (23, 24)], a second external adduct with (0,0)
at 393 nm is (()-2 (or type II′), and an intercalated
adduct (origin band at 398 nm for anti- and at 399 nm
for syn-DB[a,l]PDE adducts) is (()-3 (or type I). Our
terminology of adduct classification is used throughout
this work. The observed large red shifts are caused by
different ð-ð interactions between an adduct and the
DNA bases and also by conformational changes in the
cyclohexenyl ring of the DB[a,l]PDE adducts (33, 36).
(()-syn-DB[a,l]PDE Adducts with Polynucleotides
and CT-DNA. Adducts derived from syn-DB[a,l]PDE in
double-stranded oligonucleotides and DNA exist in mul-
tiple conformations, as summarized in Table 4. In
double-stranded poly(dG)¥poly(dC), two different external
conformations [(()-2 and (()-1] with origin bands located
at 382.5 and 392.6 nm, respectively, are formed. Previ-
ous conformational studies, including molecular dynam-
ics simulation and calculations of the UV transitions, of
syn-DB[a,l]PDE-derived depurinating DNA adducts (syn-
DB[a,l]PDE-N7Ade and syn-DB[a,l]PDE-N7Gua) have
established that trans-syn-DB[a,l]PDE adducts with (0,0)
bands at 382.5 nm correspond to a conformation in which
the cyclohexenyl ring adopts a half-boat structure, with
adenine or guanine in a pseudoaxial position and mini-
mal stacking interaction between the DNA bases and the
distal ring of DB[a,l]P (36). Therefore, the conformation
of these (()-1 adducts must correspond to an external
configuration with the cyclohexenyl ring in a half-boat
conformation and negligible interaction with the bases
of the poly(dG)¥poly(dC) oligonucleotide. The conforma-
tion of the (()-2 adducts in poly(dG)¥poly(dC), having
their origin band shifted to 393 nm, although still
external in nature, must be characterized by a significant
base-stacking interaction. Red-shifted, presumably in-
tercalated conformation [(()-3] of syn-DB[a,l]PDE-de-
rived adducts is also formed in poly(dG)¥poly(dC), with
its origin band at 399 nm. The reaction of syn-DB[a,l]-
PDE with poly(dA)¥poly(dT) and with CT-DNA in vitro
results in the formation of external but base-stacked
adducts [(()-2] and intercalated adducts [(()-3]. Al-
though these samples do not possess the blue-shifted
external (()-1 conformation observed in poly(dG)¥poly-
(dC), they do exhibit broad-band excimer-type fluores-
cence at 440 nm that is not observed for the poly(dG)¥poly-
(dC) sample. Since this excimer fluorescence has been
observed for poly(dA)¥poly(dT) and DNA samples but not
for poly(dG)¥poly(dC), it is believed to be due to external
adducts bound to neighboring adenine bases, presumably
in an external configuration. Only this type of configu-
ration could lead, in the excited state, to the observed
excimer type fluorescence.
(()-anti-DB[a,l]PDE Adducts with Polynucle-
otides and CT-DNA. It is important to note that the
adduct yield with CT-DNA is approximately 8 fmol/íg of
DNA for anti-DB[a,l]PDE and about 10-fold less for syn-
DB[a,l]PDE. Adducts derived from anti-DB[a,l]PDE in
double-stranded oligonucleotides and DNA also exist in
multiple conformations, as summarized in Table 4. In
this case, for double-stranded poly(dG)¥poly(dC), an
intercalated conformation is formed but only one external
conformation [(()-2), presumably in a half-boat confor-
mation] is observed. No blue-shifted external (()-1
conformation is observed in this case. The reaction of
anti-DB[a,l]PDE with poly(dA)¥poly(dT) and with DNA
Table 5. Compilation of Adducts Observed in Mouse Skin DNA in Vivo from Animals Treated Topically with DB[a,l]P,
Based on Laser-Excited Low-Temperature Fluorescence Spectroscopy
DB[a,l]P (in vivo)
carcinogen
sample
adduct
label
(0,0) band
(nm) adduct/conformation assignment
mouse skin DNA
(24 h after exposure)
(()-1 382.5 trans-syn-DB[a,l]PDE-dAext with possible contribution from
anti-DB[a,l]PDE-dGext and/or syn-DB[a,l]PDE-dGexta
(()-2 393.4 cis-anti-DB[a,l]PDE-dAext
(()-3 398 mixture of dAint and dGint adducts, mostly from anti-DB[a,l]PDEb
c 445 closely spaced (neighbored) anti-DB[a,l]PDE-dAextd
a Note that based on 32P-postlabeling data the (()-syn-DB[a,l]PDE-dG adduct is not formed in mouse skin and therefore it can be
excluded; however, this adduct was observed in the rat liver microsomal reaction. anti-DB[a,l]PDE-dGext [(()-1] with (0,0) band at 382.5
nm cannot be excluded, although it was not observed in in vitro studies, perhaps due to a small contamination by tetrols in the 386-nm
region. b On the basis of 32P-postlabeling results, we have shown that dAint and dGint adducts are major and minor, respectively. c External
adducts presumably formed in “hot spots”, which have runs of neighboring or closely spaced adenine bases. d A minor contribution from
syn-DB[a,l]PDE-dAext cannot be excluded.
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leads to the formation of external base-stacked adducts
[(()-2] and intercalated adducts [(()-3]. Excimer-type
fluorescence is also observed for these samples at 445 nm
[but not for poly(dG)¥poly(dC)], consistent with the
presumption that the excimer fluorescence originates
from adducts bound to neighboring or closely spaced
adenine bases in the poly(dA)¥poly(dT) and DNA samples.
Conformations of External Adducts. The confor-
mation of the anti-DB[a,l]PDE-dA adduct in single-
stranded poly(dA), obtained by denaturing the poly-
(dA)¥poly(dT) sample, is characterized as an external
(()-1 adduct. Its (0,0) band is located at 382.6 nm, as
shown in Figure 3. Recent spectroscopic data obtained
for the trans-anti-DB[a,l]PDE-dA mononucleotide showed
that this adduct may exist in two different conformations,
with (0,0) bands at 382.6 and 388.2 nm, respectively.
Detailed characterization of dA adducts will be published
separately. Other spectroscopic data, molecular model-
ing, and molecular dynamics simulations performed for
trans-anti-DB[a,l]P tetrol (35) and preliminary calcula-
tions for the trans-anti-DB[a,l]PDE-dA adduct show that
the cyclohexenyl ring of the dA adduct [as was the case
for DB[a,l]P tetrol (35)] may exist in two different half-
chair conformations. In the first conformation, the base
substituent in the fjord region at the C14-position adopts
a semiaxial position, while its orientation in the second
conformation is semiequatorial. On the basis of these
results and spectroscopic data presented in this paper,
we conclude that the external dA adducts in single-
stranded poly(dA) (origin band at 382.6 nm) differ from
the external dA adducts in double-stranded poly(dA)¥poly-
(dT) (origin band at 393.4 nm) in the conformation of the
cyclohexenyl ring and the amount of stacking interaction
with the DNA bases. Since other experimental studies
show that only trans-anti-DB[a,l]P tetrols (35) (but not
the cis-tetrols) undergo conformational changes in dif-
ferent solvent systems (35), we conclude, based on the
data shown in Figure 3, that the intercalated dA adduct
in poly(dA)¥poly(dT) with (0,0) band at 398 nm [which
yields the external dA adduct in single-stranded poly-
(dA) upon denaturation] is formed by a trans opening of
the anti-diol epoxide. Therefore, the external (()-2
adducts in poly(dA)¥poly(dT) with origin band at 393.4
nm (Figure 8, spectrum c) must correspond to adducts
formed by cis opening of the anti-diol epoxide. The
presence of this adduct and its stereochemistry, in the
case of mouse skin DNA, have been confirmed by FLN
spectra shown in Figure 9.
The external dG adducts derived from (()-syn-DB[a,l]-
PDE in poly(dG)¥poly(dC) also exhibit two external
conformations: (()-1 and (()-2 adduct types with their
origin bands at 382.5 and 392.6 nm, respectively. In this
case, on the basis of previous spectroscopic results and
molecular dynamics simulations obtained for trans-syn-
DB[a,l]P tetrols and depurinating trans-syn-DB[a,l]PDE-
N7Gua and -N7Ade adducts (36), we believe that the
band at 382.5 nm corresponds to a conformation in which
the cyclohexenyl ring adopts a boatlike structure. In-
terestingly, only one external dA adduct type (base-
stacked) with origin band at 392.5 nm is observed in
poly(dA)¥poly(dT) samples. This sample, however, shows
a significant contribution of excimer-type fluorescence
originating, presumably, from external type II adducts.
Sequence Specificity. Excimer-type fluorescence is
observed not only for the in vitro modified poly(dA)¥poly-
(dT) and DNA samples, which have high adduction levels,
but also for the mouse skin DNA samples, obtained in
vivo, that have a very low damage level. This is remark-
able and seems to indicate that there may be cooperat-
ivity effects that lead to adduct formation on neighboring
bases or that there may be regions of the DNA strand
(hot spots) that are more susceptible to adduct formation
on neighboring bases. It has been shown previously by
Ross et al. (40) using the reaction of fjord region benzo-
[c]phenanthrene-3,4-diol 1,2-epoxides with a specific gene
sequence (supF gene, 1 modification/200 base pairs) that
individual stereoisomers of diol epoxides show a remark-
able sequence specificity to produce a unique pattern of
adduct hot spots.
Comparison of 32P-Postlabeling and Fluores-
cence Results. Since the fluorescence results have been
obtained for native, adducted DNA samples, while the
32P-postlabeling results have been obtained for DNA
samples digested to the 3′-nucleotide level, different
information is obtained. The major DB[a,l]P-DNA ad-
ducts formed in mouse skin DNA in vivo, as determined
by 32P-postlabeling, are (-)-anti-DB[a,l]PDE-dA, (-)-
anti-DB[a,l]PDE-dG, and (()-syn-DB[a,l]PDE-dA (see
Tables 1 and 2). Three of the major adducts (spots 1-3
in Figure 2B) account for85% of the total stable adducts
formed in mouse skin DNA. The results of laser-induced
fluorescence spectroscopy (Table 5) indicate that the
following adducts are formed in mouse skin: anti-DB-
[a,l]PDE-dA and -dG (intercalated trans-type adducts),
cis-anti-DB[a,l]PDE-dA [external, (()-2 adduct], and a
minor external adduct, most likely (()-trans-syn-DB[a,l]-
PDE-dA, that may also include a small contribution
from (()-syn-DB[a,l]PDE-dG.
The 32P-postlabeling results indicate that in mouse skin
DNA, anti-DB[a,l]PDE adducts originate from the (-)-
enantiomer. This stereoselectivity is consistent with
previous observations made for the activation of DB[a,l]P
in MCF-7 cells (5) and mouse skin (6). The fluorescence
data, while not providing information on chirality, yields
information regarding the conformations of the adducts;
external [(()-1], external base-stacked [(()-2], and in-
tercalated [(()-3] adducts all form in mouse skin DNA
exposed to DB[a,l]P. On the basis of fluorescence spec-
troscopy and molecular modeling and dynamics simula-
tions, the two major dA adducts derived from anti-
DB[a,l]P diol epoxide (spots 2 and 3 in the 32P-postlabeling
results in Figure 2B) correspond to cis (origin band at
393.4 nm) and trans (origin band at 398 nm) addition,
respectively. The 32P-postlabeling and fluorescence re-
sults can also be combined to confirm or discount the
formation of specific adducts. For instance, a possibility
of a minor contribution from (()-syn-DB[a,l]PDE-dG in
mouse skin DNA, which could not be excluded based on
the fluorescence data, can be rejected, since only (()-syn-
dA [not (()-syn-dG] adducts were positively identified by
32P-postlabeling.
Low-temperature fluorescence spectroscopy can dif-
ferentiate between different conformations of DNA ad-
ducts and reveal differences in their repair rates. The
analysis of mouse skin DNA samples obtained at 24 and
48 h after exposure to DB[a,l]P clearly shows that
external adducts are repaired more efficiently than
intercalated adducts. The structure of one of these
adducts, cis-anti-DB[a,l]PDE-dA (spot 2, Figure 2B), an
external (()-2 type adduct, has been identified by FLN
spectroscopy (Figure 9). A minor external (()-1 type
adduct, i.e., (()-trans-syn-DB[a,l]PDE-dA (tentatively
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assigned as spot 4 in the 32P-postlabeling data in Figure
2B), is also preferentially repaired. The identity of this
minor adduct (origin band at 382.5 nm in Figure 8) has
been assigned based on spectroscopic and computational
analysis of various DB[a,l]P diol epoxide adduct stan-
dards and their tetrol hydrolysis products. Thus the
fluorescence results indicate that conformation-depend-
ent repair of DB[a,l]P-DNA adducts occurs, as has been
observed previously for mouse skin DNA exposed to B[a]P
(20).
Conclusions
The present study has shown that the combination of
32P-postlabeling and low-temperature fluorescence spec-
troscopy provides a powerful methodology for investigat-
ing the structures and conformations of DNA adducts,
including adduct heterogeneity, persistence, and repair.
The two methods are complementary and provide more
insight into adduct formation and composition than
either method alone can provide.
DB[a,l]P-DNA adducts that form in mouse skin
exposed to DB[a,l]P are very heterogeneous, possessing
different structures and different conformations. Exter-
nal [(()-1 type], external but base-stacked [(()-2], and
intercalated [(()-3] adduct conformations are all observed
in mouse skin DNA samples. Based on the 32P-postla-
beling and fluorescence data, it can be estimated that
the majority (approximately 75%) of the adducts formed
in mouse skin DNA at 24 h adopt intercalated conforma-
tions that are less efficiently repaired than external
adducts. Taken together with our recent data on B[a]P-
DNA adducts (20), it seems that the DNA repair system
differentiates between adduct structure and conformation
in the process of repairing DNA damage resulting from
PAH diol epoxides.
The finding that DB[a,l]PDE-dA adducts are the
major adducts formed in mouse skin DNA in vivo is in
agreement with an earlier study performed in MCF-7 cell
cultures, where 80-90% of the adducts were attributed
to adenine modification (5). In other studies the ratio of
guanine to adenine adducts was nearer 1:1 (41). How-
ever in these studies, the first involving microsomal
activation of the hydrocarbon and the second an analysis
of adducts in mouse lung following ip injection, a signifi-
cant proportion of the adducts were formed by the syn-
diol epoxide. In mouse skin, however, the overwhelming
majority of adducts are formed by the (-)-anti-diol
epoxide (ref 6 and this study), which appears to show a
greater selectivity for adenine residues. In the present
study we detected only a small contribution to DNA
binding (ca. 3%) by the syn-diol epoxides; an earlier study
failed to detect any contribution by these isomers to DNA
binding in mouse skin (6).
All studies indicate that stable DB[a,l]PDE-DNA
adducts are formed in vivo by the metabolic activation
of DB[a,l]P to the fjord region DB[a,l]P-11,12-diol 13,14-
epoxides, which subsequently react with dA and dG
residues presumably at the exocyclic amino groups, as
has been demonstrated also for a variety of other PAH
diol epoxides (42-44). In contrast, binding of DB[a,l]-
PDE at the N7 positions of dA and dG has been shown
to lead to depurination in vitro (9). Further studies on
adduct composition, their repair, and mutational events
caused by adducts derived from DB[a,l]P (via both
monooxygenation and one-electron oxidation pathways)
will be required to establish a correlation between
mutations and the DB[a,l]P adduct structure involved.
Although fluorescence analysis was able to reveal
differences in the relative rates of repair of adducts
between 24 and 48 h, these were not evident from
analysis by 32P-postlabeling. The probable reasons for
this are that the variations in quantitation inherent in
this method are too great to detect small absolute
differences in the percentage contributions of individual
adduct spots to the total binding. Alternatively, the fact
that the different repair rates are not reflected in the
postlabeling spots is because several adducts may exist
as both external (minor) and intercalated (major) con-
formations. Then, if for all these adducts some of the
minor population is repaired more readily, the relative
intensities of the adduct spots would still be more or less
the same.
Nevertheless, the spectroscopic study presented in this
manuscript indicates that a relatively high amount of
DB[a,l]PDE-DNA adducts adopt intercalated conforma-
tions and are, therefore, more resistant to repair than
external adducts. This may be one of the reasons that
DB[a,l]P is the most potent PAH carcinogen presently
known (1-15).
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